Czechia· CZ-0225174
TOBREX
A tobramycin product containing tobramycin, registered in Czechia by Novartis s.r.o., Praha. The same ATC class is registered in 10 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Tobramycin is registered in 10 of 19 countries.
Countries holding a registration under ATC S01AA12 (tobramycin), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 7 of them publish a price we can compare per daily dose
Tobramycin · ATC S01AA12
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- TOBRAMYCIN
- Manufacturer
- Novartis s.r.o., Praha
- Country
- Czechia (CZ)
- ATC code
- S01AA12
- ATC class
- Tobramycin
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl02251743,5GCZK 81.09
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tobramycin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandTobrexForfarm Sp. z o.o.
- SpainTOBREX UNGÜENTO OFTÁLMICO 3 MG/G POMADA OFTÁLMICANovartis Farmaceutica S.A.
- United StatesTOBREXNovartis Pharmaceuticals Corporation
- United KingdomBramitob 300mg/4ml nebuliser solution 4ml ampoulesChiesi Ltd
- GermanyBramitobChiesi Gmbh
- FinlandNebcinaEli Lilly Finland Oy Ab
- SwedenBramitob 300 mg Lösning för nebulisatorChiesi Farmaceutici S.p.A.
- NetherlandsBramitob, verneveloplossing 300 mg/4 mlChiesi Pharmaceuticals B.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Bramitob, Tobi
- Belgium · Obracin, Tobi
- Bulgaria · Tобрекс, Тобрамизил
- Cyprus · Bramitob, Ikobel
- Germany · Bramitob, Gernebcin
- Denmark · Nebcina, Tobi
- Estonia · Tobramycin Via Pharma, Tobrex
- Spain · Bramitob, Tobrabact
- Finland · Tobi
- France · Nebcine, Tobi
- United Kingdom (Northern Ireland) · Bramitob, Munuza
- Greece · Bramitob, Eyetobrin
- Croatia · Bramitob, Tobrex
- Hungary · Bramitob, Brulamycin
- Ireland · Bramitob, Tobi
- Iceland · Tobi Podhaler, Vantobra
- Italy · Bramicil, Bramitob
- Liechtenstein · Tobi Podhaler, Vantobra
- Lithuania · Bramitob, Tobramycin Via Pharma
- Luxembourg · Obracin, Tobi
- Latvia · Bramitob, Tobramycin Via Pharma
- Malta · Tobi, Tobrex
- Netherlands · Bramitob, Obracin
- Norway · Bramitob, Nebcina
- Poland · Bramitob, Tobramycin Via Pharma
- Portugal · Bramitob, Tobi
- Romania · Tobi, Tobramicină Sun
- Sweden · Bramitob, Nebcina
- Slovenia · Tobrex
- Slovakia · Bramitob, Tobrex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3a6a2cec-a36c-4090-a17a-598915f00375 GET /v1/drugs/3a6a2cec-a36c-4090-a17a-598915f00375?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "OPH UNG",
"source": "sukl",
"strength": "3MG/G",
"pack_size": "3,5G",
"substance": "TOBRAMYCIN",
"cz_kod_sukl": "0225174",
"product_type": "CH",
"substance_codes": "3374",
"registration_state": "R",
"registration_number": "64/128/91-C"
}See everything about tobramycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.